Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to investigate the safety of different doses of sublingual tablets of house dust mite allergen extracts in adults with house dust mite-associated allergic asthma.
Epistemonikos ID: 8d12ec4df74c133a6a46ffdc4d19d3f465810203
First added on: May 11, 2024